Unexpected outcomes sound warning for treatment of genetic diseases using gene editing in embryos

August 9, 2018, University of Adelaide
Credit: CC0 Public Domain

New research led by the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide has uncovered a significant hurdle for realising the potential benefits of gene editing in embryos.

The team, led by Professor Paul Thomas, investigated North American research published last year that seemed to demonstrate that in was highly effective in repairing a in a majority of the embryos.

Professor Thomas says their research provides an alternative explanation for the apparent gene correction, demonstrating that rather than the gene editing technology fixing small errors, much larger errors were being created.

"Gene editing technology is still relatively new, and part of this field of research includes understanding the flaws, which will ultimately allow us to develop the safest possible therapies for genetic conditions," Professor Thomas said.

Professor Thomas and the research paper's first author, Dr. Fatwa Adikusuma, replicated the North American study with preclinical animal models. Australia has strict legislation restricting gene editing in human embryos.

"We looked beyond the small deletions, exploring larger areas of DNA," Dr. Adikusuma said.

"When we searched a wider area, we found that repair of the DNA break generated by 'molecular scissors' resulted in deletion of large stretches of DNA."

The molecular scissors, or CRISPR-Cas9 as they are scientifically known, are a tool utilised by scientists to cut specific regions of a cell's genetic material (DNA). Repair of the cut can alter the target DNA sequence, resulting in a specific change or "edit". Faulty can theoretically be repaired by cutting them using CRISPR scissors. However, as Professor Thomas and his colleagues have shown, DNA can sometimes be lost during the repair process, resulting in large deletions that would not restore function to the faulty gene.

"CRISPR-Cas9 technology is very exciting, with researchers already using it to cure muscular dystrophy in mice, and a number of clinical trials are underway to test gene editing therapies for several cancers as well as blood diseases," Professor Thomas said.

"Understanding the fundamental mechanisms by which these tools work are important advancements for research and for clinical translation to treat a host of genetic diseases."

The research findings were published online today in the British multidisciplinary science journal Nature.

Explore further: Genome-editing tool could increase cancer risk

More information: Fatwa Adikusuma et al. Large deletions induced by Cas9 cleavage, Nature (2018). DOI: 10.1038/s41586-018-0380-z

Related Stories

Genome-editing tool could increase cancer risk

June 11, 2018
Therapeutic use of gene editing with the CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published ...

Gene-editing damages DNA more than previously thought: study

July 16, 2018
A revolutionary gene editing technique hailed as the future of disease eradication and mooted for a Nobel prize may be less precise and cause more cell damage than previously thought, researchers said Monday.

Recommended for you

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

October 22, 2018
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, ...

New tool gives deeper understanding of glioblastoma

October 22, 2018
Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to study genetic "switches" active in glioblastoma tumors that drive growth of the cancer. In a new paper in Nature ...

Researchers find common genetic link in lung ailments

October 22, 2018
An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary ...

Scientists identify critical cancer immunity genes using new genetic barcoding technology

October 20, 2018
Scientists at Mount Sinai have developed a novel technology for simultaneously analyzing the functions of hundreds of genes with resolution reaching the single cell level. The technology relies on a barcoding approach using ...

A single missing gene leads to miscarriage

October 19, 2018
A single gene from the mother plays such a crucial role in the development of the placenta that its dysfunction leads to miscarriages. Researchers from the Medical Faculty of Ruhr-Universität Bochum (RUB) have observed this ...

Making gene therapy delivery safer and more efficient

October 18, 2018
Viral vectors used to deliver gene therapies undergo spontaneous changes during manufacturing which affects their structure and function, found researchers from the Perelman School of Medicine at the University of Pennsylvania ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.